Key result
Simvastatin, atorvastatin, fluvastatin and pravastatin reduced platelet activity after 1, 2, 3 and 4 weeks of treatment, respectively.
Why the study?
Do different statins have a time-dependent effect on platelet function in hypercholesterolaemic subjects?
Do different statins have a time-dependent effect on platelet function in hypercholesterolaemic subjects?
Different statins reduce platelet activity at varying time points, with the early antiplatelet effect appearing to be related to interference with platelet-associated ox-LDL rather than LDL-C reduction.
Answers are grounded in this paper and cite their sources.
Should not yet alter statin choice; leaves open whether time-dependent platelet effects improve outcomes.
BACKGROUND: Reduction of platelet activity induced by statins has been described as a positive effect exerted by such molecules on vascular thrombotic events. However, the relations among cholesterol (LDL-C) reduction, the timing of the antiplatelet effect, the involved mechanisms and the doses of each statin able to reduce platelet function are not actually well known. The aim of our study was to evaluate the impact of simvastatin (20 mg day-1), atorvastatin (10 mg day-1), fluvastatin (40 mg day-1) and pravastatin (40 mg day-1) on platelet function in hypercholesterolaemic subjects with relation to (LDL-C), oxidized-LDL (ox-LDL) and antiport mechanism modifications. MATERIALS AND METHODS: Sixteen subjects were assigned to each treatment (40 males, 24 females, mean age 48.7 +/- 13.4, LDL-C 5.13 +/- 0,23 mmol L-1) and evaluated for platelet surface P-selectin (P-sel), lipid profile, ox-LDL, platelet-associated ox-LDL (Pox-LDL), platelet cholesterol content, antiport mechanisms, and intracellular and systemic NO synthase every 7 days for one month. RESULTS: Our data show a strong relation between enhanced P-sel and Pox-LDL (r = 0.68, P < 0.01). Simvastatin, atorvastatin, fluvastatin and pravastatin reduce platelet activity after 1, 2, 3 and 4 weeks of treatment, respectively (P < 0.001, P < 0.001, P < 0.01, P < 0.05). Pox-LDL are modulated early by simvastatin, atorvastatin and fluvastatin Pox-LDL (r = 0.66, 0.65 and 0.52; P < 0.001, 0.001 and 0.01, respectively) whereas LDL-C and ox-LDL reductions associated to modifications of antiport activity act later. Moreover, they are the most relevant finding in pravastatin-related subjects. CONCLUSIONS: Our data suggest a different impact of several statins on platelet function, which is initially related to interference with Pox-LDL rather than LDL-C reduction.
No takes yet. Share an insight, caveat, or question.
Puccetti et al. (2002) studied Hypercholesterolaemia (n=64). Statins (simvastatin, atorvastatin, fluvastatin, pravastatin) was evaluated on Platelet activity. Simvastatin, atorvastatin, fluvastatin and pravastatin reduced platelet activity after 1, 2, 3 and 4 weeks of treatment, respectively.
Synapse has enriched 10 related papers. Consider them for comparative context: